Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection

Jia Xu, Tina Tyan, Edward Cedrone, Niramol Savaraj, Nancy Wang

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Chromosomal homogeneous staining region (hsr), which is a cytogenetic indication of gene amplification, was found in the pleural effusion (BHII) of a patient with small cell lung cancer (SCLC) after failure of multiple drug treatments. Amplification of band 11q13 was identified as the origin of the hsr by means of chromosomal microdissection combined with G-banding, DNA amplification by polymerase chain reaction, and fluorescence in situ hybridization (micro-FISH). In situ hybridization with the biotin-labeled DNA probe generated from the hsrs of BHII to the cell line BHI, which was established from the lymph node metastasis prior to chemotherapy, revealed the preexistence of 11q13 amplification. This ruled out the possibility of therapeutic induction of the 11q13 amplification. However, the hsr-bearing marker chromosomes were identified by the micro-FISH approach as der(21)(Xqter-→Xq24::hsr(II)(q13)::21p11→21qter) in BHII but as der(11)t(3;11)(q21;q13)hsr(11)(q13) in BHI. This suggests that 11q13 DNA sequence amplification may occur first and is then followed by various types of structural rearrangements. FISH analysis with INT2/FGF3 and HST1/FGF4 probes revealed that these protooncogenes were coamplified in the hsrs of BHI and BHII. The results obtained suggest that 11q13 amplification and the successive structural rearrangement may play an important role in the progression of the disease and its therapeutic response.

Original languageEnglish
Pages (from-to)172-178
Number of pages7
JournalGenes Chromosomes and Cancer
Volume17
Issue number3
DOIs
StatePublished - Nov 1 1996

Fingerprint

Microdissection
Small Cell Lung Carcinoma
Chromosomes
Staining and Labeling
Gene Amplification
DNA Probes
Pleural Effusion
DNA-Directed DNA Polymerase
Biotin
Fluorescence In Situ Hybridization
Genetic Markers
Cytogenetics
In Situ Hybridization
Disease Progression
Therapeutics
Lymph Nodes
Neoplasm Metastasis
Drug Therapy
Cell Line
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection. / Xu, Jia; Tyan, Tina; Cedrone, Edward; Savaraj, Niramol; Wang, Nancy.

In: Genes Chromosomes and Cancer, Vol. 17, No. 3, 01.11.1996, p. 172-178.

Research output: Contribution to journalArticle

@article{75280c28a9f444ae8d6f1734f409d11b,
title = "Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection",
abstract = "Chromosomal homogeneous staining region (hsr), which is a cytogenetic indication of gene amplification, was found in the pleural effusion (BHII) of a patient with small cell lung cancer (SCLC) after failure of multiple drug treatments. Amplification of band 11q13 was identified as the origin of the hsr by means of chromosomal microdissection combined with G-banding, DNA amplification by polymerase chain reaction, and fluorescence in situ hybridization (micro-FISH). In situ hybridization with the biotin-labeled DNA probe generated from the hsrs of BHII to the cell line BHI, which was established from the lymph node metastasis prior to chemotherapy, revealed the preexistence of 11q13 amplification. This ruled out the possibility of therapeutic induction of the 11q13 amplification. However, the hsr-bearing marker chromosomes were identified by the micro-FISH approach as der(21)(Xqter-→Xq24::hsr(II)(q13)::21p11→21qter) in BHII but as der(11)t(3;11)(q21;q13)hsr(11)(q13) in BHI. This suggests that 11q13 DNA sequence amplification may occur first and is then followed by various types of structural rearrangements. FISH analysis with INT2/FGF3 and HST1/FGF4 probes revealed that these protooncogenes were coamplified in the hsrs of BHI and BHII. The results obtained suggest that 11q13 amplification and the successive structural rearrangement may play an important role in the progression of the disease and its therapeutic response.",
author = "Jia Xu and Tina Tyan and Edward Cedrone and Niramol Savaraj and Nancy Wang",
year = "1996",
month = "11",
day = "1",
doi = "10.1002/(SICI)1098-2264(199611)17:3<172::AID-GCC5>3.0.CO;2-1",
language = "English",
volume = "17",
pages = "172--178",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection

AU - Xu, Jia

AU - Tyan, Tina

AU - Cedrone, Edward

AU - Savaraj, Niramol

AU - Wang, Nancy

PY - 1996/11/1

Y1 - 1996/11/1

N2 - Chromosomal homogeneous staining region (hsr), which is a cytogenetic indication of gene amplification, was found in the pleural effusion (BHII) of a patient with small cell lung cancer (SCLC) after failure of multiple drug treatments. Amplification of band 11q13 was identified as the origin of the hsr by means of chromosomal microdissection combined with G-banding, DNA amplification by polymerase chain reaction, and fluorescence in situ hybridization (micro-FISH). In situ hybridization with the biotin-labeled DNA probe generated from the hsrs of BHII to the cell line BHI, which was established from the lymph node metastasis prior to chemotherapy, revealed the preexistence of 11q13 amplification. This ruled out the possibility of therapeutic induction of the 11q13 amplification. However, the hsr-bearing marker chromosomes were identified by the micro-FISH approach as der(21)(Xqter-→Xq24::hsr(II)(q13)::21p11→21qter) in BHII but as der(11)t(3;11)(q21;q13)hsr(11)(q13) in BHI. This suggests that 11q13 DNA sequence amplification may occur first and is then followed by various types of structural rearrangements. FISH analysis with INT2/FGF3 and HST1/FGF4 probes revealed that these protooncogenes were coamplified in the hsrs of BHI and BHII. The results obtained suggest that 11q13 amplification and the successive structural rearrangement may play an important role in the progression of the disease and its therapeutic response.

AB - Chromosomal homogeneous staining region (hsr), which is a cytogenetic indication of gene amplification, was found in the pleural effusion (BHII) of a patient with small cell lung cancer (SCLC) after failure of multiple drug treatments. Amplification of band 11q13 was identified as the origin of the hsr by means of chromosomal microdissection combined with G-banding, DNA amplification by polymerase chain reaction, and fluorescence in situ hybridization (micro-FISH). In situ hybridization with the biotin-labeled DNA probe generated from the hsrs of BHII to the cell line BHI, which was established from the lymph node metastasis prior to chemotherapy, revealed the preexistence of 11q13 amplification. This ruled out the possibility of therapeutic induction of the 11q13 amplification. However, the hsr-bearing marker chromosomes were identified by the micro-FISH approach as der(21)(Xqter-→Xq24::hsr(II)(q13)::21p11→21qter) in BHII but as der(11)t(3;11)(q21;q13)hsr(11)(q13) in BHI. This suggests that 11q13 DNA sequence amplification may occur first and is then followed by various types of structural rearrangements. FISH analysis with INT2/FGF3 and HST1/FGF4 probes revealed that these protooncogenes were coamplified in the hsrs of BHI and BHII. The results obtained suggest that 11q13 amplification and the successive structural rearrangement may play an important role in the progression of the disease and its therapeutic response.

UR - http://www.scopus.com/inward/record.url?scp=0029955068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029955068&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2264(199611)17:3<172::AID-GCC5>3.0.CO;2-1

DO - 10.1002/(SICI)1098-2264(199611)17:3<172::AID-GCC5>3.0.CO;2-1

M3 - Article

C2 - 8946196

AN - SCOPUS:0029955068

VL - 17

SP - 172

EP - 178

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 3

ER -